Back
ESC Professional Premium Access

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Session: Improving pharmacotherapy in primary prevention
Topic: Lipid-Lowering Agents
Speaker: Doctor Q. Chan (Greater London, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Queenie Chan

Amgen Ltd, Greater London (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

Speaker: Doctor A. Bech-Drewes (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

Speaker: Professor D. Bhatt (New York, US)

Access
Abstract